Mark Little PhD

Mark is currently President & Global Head of Strategic Planning at Prescient Healthcare Group (PHG). Mark is a globally recognized senior executive in competitive intelligence and strategic analysis. For over 20 years he has been a trusted advisor to biopharmaceutical executives. His insights into the marketplace have resulted in hundreds of millions of dollar value to organizations for which he has worked. Prior to joining PHG), Mark built and led the intelligence efforts at GlaxoSmithKline (1993-2002), where he served in various leadership roles in the R&D and Commercial Strategy organizations. Further, Mark built and led the intelligence efforts at Covance, a leading public contract research organization (CRO). As Vice President of Business Intelligence and Market Research, he contributed to decisions leading to significant growth in revenue and profits over ten years to 2012.

Mark is a former President of the Strategic and Competitive Intelligence (SCIP) Association, and has served in various capacities with SCIP, including a five-year stint as a Board Member, three years as Chair, Council of SCIP Fellows, and one year at the Ethics Chair. He was a recipient of the SCIP Fellows award in 2005, and recipient of the SCIP Meritorious in 2014, and is currently a member of the Intelligence Leadership Forum (ILF), and serves on the executive committee of ILF.

Mark has a Ph.D. in Biochemistry from The Ohio State University, a B.S. degree in Chemistry from the University of North Carolina, and held post-doctoral positions at the Department of Pediatrics at UNC, and as a NSF fellow, at the Centre Nationale de la Reserche Scientific in Grenoble, France